TrialAdvances in therapy2025

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux

Jia Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.